\-\ Texto\\:\\ \ \(0\)\
\-\ routine\\ labs\\ showed\\ anemia\ \(0\)\
\-\ air\\-contrast\\ be\\:\\ concentric\\ narrowing\\ \\‚\\Ä\\úapple\\ core\\‚\\Ä\\ù\\ lesion\\ of\\ the\\ proximal\\ descending\\ colon\\.\\ \\ \ \(0\)\
\-\ ct\\:\\ corresponds\\ to\\ be\\ findings\\ of\\ a\\ concentrically\\ narrowed\\ lesion\\ of\\ the\\ colon\\ without\\ invasion\\ of\\ the\\ abdominal\\ wall\\ or\\ distant\\ metastases\\.\ \(0\)\
\-\ colon\\ adenocarcinoma\ \(0\)\
\-\ primary\\ colon\\ cancer\ \(1\)\
\-\ metastatic\\ lesion\ \(30\)\
\-\ lymphoma\ \(373\)\
\-\ leiomyoma\ \(85\)\
\-\ leiomyosarcoma\ \(24\)\
\-\ post\\-inflammatory\\ stricture\ \(0\)\
\-\ 34\\ y\\.o\\.\\ woman\\ for\\ screening\\ colonoscopy\\.\\ \\ the\\ gi\\ attending\\ was\\ unable\\ to\\ pass\\ the\\ endoscope\\ beyond\\ the\\ descending\\ colon\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ colon\\:\\ 0\\.21512390447579097\ \(0\)\
\-\ concentrically\\:\\ 0\\.11301946697392946\ \(0\)\
\-\ descending\\:\\ 0\\.10695198781602887\ \(0\)\
\-\ air\\-contrast\\:\\ 0\\.10413296465905837\ \(0\)\
\-\ endoscope\\:\\ 0\\.09524646234418727\ \(0\)\
\-\ post\\-inflammatory\\:\\ 0\\.09238564758374869\ \(0\)\
\-\ attending\\:\\ 0\\.09004819172741593\ \(0\)\
\-\ apple\\:\\ 0\\.08116168941254484\ \(0\)\
\-\ concentric\\:\\ 0\\.07339071757189977\ \(0\)\
\-\ leiomyosarcoma\\:\\ 0\\.07227518709767375\ \(0\)\
\-\ corresponds\\:\\ 0\\.06984900761512851\ \(0\)\
\-\ lesion\\:\\ 0\\.06694443176924826\ \(0\)\
\-\ narrowed\\:\\ 0\\.06605072792098528\ \(0\)\
\-\ leiomyoma\\:\\ 0\\.06450421525702868\ \(0\)\
\-\ distant\\:\\ 0\\.06393432086509492\ \(0\)\
\-\ colonoscopy\\:\\ 0\\.06393432086509492\ \(0\)\
\-\ beyond\\:\\ 0\\.06365860028533897\ \(0\)\
\-\ pass\\:\\ 0\\.06312433494687014\ \(0\)\
\-\ core\\:\\ 0\\.06074334589821511\ \(0\)\
\-\ stricture\\:\\ 0\\.05873605024832357\ \(0\)\
\-\ anemia\\:\\ 0\\.054502182467931565\ \(0\)\
\-\ 34\\:\\ 0\\.05436932622388609\ \(0\)\
\-\ invasion\\:\\ 0\\.052756898181719\ \(0\)\
\-\ unable\\:\\ 0\\.050615179147575844\ \(0\)\
\-\ gi\\:\\ 0\\.04921518822494774\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.04732762108414409\ \(0\)\
\-\ metastases\\:\\ 0\\.04680426218003826\ \(0\)\
\-\ screening\\:\\ 0\\.04673121062728649\ \(0\)\
\-\ routine\\:\\ 0\\.04392880377115381\ \(0\)\
\-\ narrowing\\:\\ 0\\.04392880377115381\ \(0\)\
\-\ \\‚\\Ä\\ú\\:\\ 0\\.04091667843306615\ \(0\)\
\-\ \\‚\\Ä\\ù\\:\\ 0\\.04068732503882544\ \(0\)\
\-\ labs\\:\\ 0\\.038102230858142794\ \(0\)\
\-\ cancer\\:\\ 0\\.03601493928672776\ \(0\)\
\-\ showed\\:\\ 0\\.03592055471697047\ \(0\)\
\-\ be\\:\\ 0\\.033788633931895615\ \(0\)\
\-\ proximal\\:\\ 0\\.03289157925265404\ \(0\)\
\-\ primary\\:\\ 0\\.03245364439609867\ \(0\)\
\-\ wall\\:\\ 0\\.03173280923383008\ \(0\)\
\-\ y\\.o\\:\\ 0\\.031620249135726926\ \(0\)\
\-\ lymphoma\\:\\ 0\\.0313102389024293\ \(0\)\
\-\ \\:\\:\\ 0\\.02898140553822218\ \(0\)\
\-\ metastatic\\:\\ 0\\.02757832568738577\ \(0\)\
\-\ abdominal\\:\\ 0\\.027383579975924555\ \(0\)\
\-\ without\\:\\ 0\\.025795040594335385\ \(0\)\
\-\ woman\\:\\ 0\\.025306448044729566\ \(0\)\
\-\ findings\\:\\ 0\\.02331842225371743\ \(0\)\
\-\ ct\\:\\ 0\\.015324405812718498\ \(0\)\
\-\ or\\:\\ 0\\.012840035243124454\ \(0\)\
\-\ was\\:\\ 0\\.012670224643765216\ \(0\)\
\-\ to\\:\\ 0\\.01095046431905093\ \(0\)\
\-\ the\\:\\ 0\\.010634560361817369\ \(0\)\
\-\ for\\:\\ 0\\.009347540367214297\ \(0\)\
\-\ of\\:\\ 0\\.0059745538870763296\ \(0\)\
\-\ a\\:\\ 0\\.005084612843828221\ \(0\)\
\-\ \\.\\:\\ 0\\.0022756112882914275\ \(0\)\
